Contribution of Membrane Mucins to Tumor Progression Through Modulation of Cellular Growth Signaling Pathways

Current Topics in Developmental Biology

Volumn 78, Issue , 2007, Pages 1-22

  Carraway III, Kermit L ^a   Funes, Melanie ^a   Workman, Heather C ^a   Sweeney, Colleen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MUCIN;

ANIMAL; CELL PROLIFERATION; DISEASE COURSE; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL PROLIFERATION; DISEASE PROGRESSION; HUMANS; MEMBRANE PROTEINS; MUCINS; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 33847328331     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2153(06)78001-2     Document Type: Review

References (112)

1. Al Masri A., and Gendler S.J. Muc1 affects c-Src signaling in PyV MT-induced mammary tumorigenesis. Oncogene 24 (2005) 5799-5808
2. Andrechek E.R., Laing M.A., Girgis-Gabardo A.A., Siegel P.M., Cardiff R.D., and Muller W.J. Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers. Cancer Res. 63 (2003) 4920-4926
3. Arango M.E., Li P., Komatsu M., Montes C., Carraway C.A., and Carraway K.L. Production and localization of Muc4/sialomucin complex and its receptor tyrosine kinase ErbB2 in the rat lacrimal gland. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2749-2756
4. Baldus S.E., Engelmann K., and Hanisch F.G. MUC1 and the MUCs: A family of human mucins with impact in cancer biology. Crit. Rev. Clin. Lab. Sci. 41 (2004) 189-231
5. Baldus S.E., Monig S.P., Huxel S., Landsberg S., Hanisch F.G., Engelmann K., Schneider P.M., Thiele J., Holscher A.H., and Dienes H.P. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin. Cancer Res. 10 (2004) 2790-2796
6. Bieche I., Onody P., Tozlu S., Driouch K., Vidaud M., and Lidereau R. Prognostic value of ERBB family mRNA expression in breast carcinomas. Int. J. Cancer 106 (2003) 758-765
7. Bienz M. β-Catenin: A pivot between cell adhesion and Wnt signalling. Curr. Biol. 15 (2005) R64-R67
8. Bobek L.A., Tsai H., Biesbrock A.R., and Levine M.J. Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J. Biol. Chem. 268 (1993) 20563-20569
9. Boshell M., Lalani E.N., Pemberton L., Burchell J., Gendler S., and Taylor-Papadimitriou J. The product of the human MUC1 gene when secreted by mouse cells transfected with the full-length cDNA lacks the cytoplasmic tail. Biochem. Biophys. Res. Commun. 185 (1992) 1-8
10. Cao Y., Blohm D., Ghadimi B.M., Stosiek P., Xing P.X., and Karsten U. Mucins (MUC1 and MUC3) of gastrointestinal and breast epithelia reveal different and heterogeneous tumor-associated aberrations in glycosylation. J. Histochem. Cytochem. 45 (1997) 1547-1557
11. Carraway III K.L., and Cantley L.C. A neu acquaintance for erbB3 and erbB4: A role for receptor heterodimerization in growth signaling. Cell 78 (1994) 5-8
12. Carraway III K.L., and Sweeney C. EGF receptor activation by heterologous mechanisms. Cancer Cell 1 (2002) 405-406
13. Carraway III K.L., Rossi E.A., Komatsu M., Price-Schiavi S.A., Huang D., Guy P.M., Carvajal M.E., Fregien N., Carraway C.A., and Carraway K.L. An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling. J. Biol. Chem. 274 (1999) 5263-5266
14. Carraway K.L., Price-Schiavi S.A., Komatsu M., Jepson S., Perez A., and Carraway C.A. Muc4/sialomucin complex in the mammary gland and breast cancer. J. Mammary Gland Biol. Neoplasia 6 (2001) 323-337
15. Carraway K.L., Ramsauer V.P., Haq B., and Carothers Carraway C.A. Cell signaling through membrane mucins. Bioessays 25 (2003) 66-71
16. Chen Y., Zhao Y.H., Kalaslavadi T.B., Hamati E., Nehrke K., Le A.D., Ann D.K., and Wu R. Genome-wide search and identification of a novel gel-forming mucin MUC19/Muc19 in glandular tissues. Am. J. Respir. Cell Mol. Biol. 30 (2004) 155-165
17. Choudhury A., Moniaux N., Winpenny J.P., Hollingsworth M.A., Aubert J.P., and Batra S.K. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. J. Biochem. (Tokyo) 128 (2000) 233-243
18. Clevers H. Signaling mucins in the (S)limelight. Dev. Cell 7 (2004) 150-151
19. Correa I., Plunkett T., Vlad A., Mungul A., Candelora-Kettel J., Burchell J.M., Taylor-Papadimitriou J., and Finn O.J. Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration. Immunology 108 (2003) 32-41
20. Cullen P.J., Sabbagh Jr. W., Graham E., Irick M.M., van Olden E.K., Neal C., Delrow J., Bardwell L., and Sprague Jr. G.F. A signaling mucin at the head of the Cdc42- and MAPK-dependent filamentous growth pathway in yeast. Genes Dev. 18 (2004) 1695-1708
21. Escande F., Lemaitre L., Moniaux N., Batra S.K., Aubert J.P., and Buisine M.P. Genomic organization of MUC4 mucin gene. Towards the characterization of splice variants. Eur. J. Biochem. 269 (2002) 3637-3644
22. Eymin B., Sordet O., Droin N., Munsch B., Haugg M., Van de Craen M., Vandenabeele P., and Solary E. Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27Kip1 mediates its anti-apoptotic activity. Oncogene 18 (1999) 4839-4847
23. Fowler J., Vinall L., and Swallow D. Polymorphism of the human muc genes. Front. Biosci. 6 (2001) D1207-D1215
24. Funes M., Miller J.K., Lai C., Carraway III K.L., and Sweeney C. The mucin MUC4 potentiates neuregulin signaling by increasing the cell-surface populations of ErbB2 and ErbB3. J. Biol. Chem. 281 (2006) 19310-19319
25. Gipson I.K. Distribution of mucins at the ocular surface. Exp. Eye Res. 78 (2004) 379-388
26. Guy C.T., Cardiff R.D., and Muller W.J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12 (1992) 954-961
27. Guy P.M., Platko J.V., Cantley L.C., Cerione R.A., and Carraway III K.L. Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc. Natl. Acad. Sci. USA 91 (1994) 8132-8136
28. Haugh J.M., and Meyer T. Active EGF receptors have limited access to PtdIns(4,5) P(2) in endosomes: Implications for phospholipase C and PI 3-kinase signaling. J. Cell Sci. 115 (2002) 303-310
29. Hellyer N.J., Kim M.S., and Koland J.G. Heregulin-dependent activation of phosphoinositide 3-kinase and Akt via the ErbB2/ErbB3 co-receptor. J. Biol. Chem. 276 (2001) 42153-42161
30. Higuchi T., Orita T., Katsuya K., Yamasaki Y., Akiyama K., Li H., Yamamoto T., Saito Y., and Nakamura M. MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met. Mol. Cell. Biol. 24 (2004) 7456-7468
31. Hilkens J., Ligtenberg M.J., Vos H.L., and Litvinov S.V. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem. Sci. 17 (1992) 359-363
32. Holbro T., Civenni G., and Hynes N.E. The ErbB receptors and their role in cancer progression. Exp. Cell Res. 284 (2003) 99-110
33. Holbro T., Beerli R.R., Maurer F., Koziczak M., Barbas III C.F., and Hynes N.E. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc. Natl. Acad. Sci. USA 100 (2003) 8933-8938
34. Hu Y.P., Haq B., Carraway K.L., Savaraj N., and Lampidis T.J. Multidrug resistance correlates with overexpression of Muc4 but inversely with P-glycoprotein and multidrug resistance related protein in transfected human melanoma cells. Biochem. Pharmacol. 65 (2003) 1419-1425
35. Huang L., Ren J., Chen D., Li Y., Kharbanda S., and Kufe D. MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation. Cancer Biol. Ther. 2 (2003) 702-706
36. Huang L., Chen D., Liu D., Yin L., Kharbanda S., and Kufe D. MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin. Cancer Res. 65 (2005) 10413-10422
37. Jentoft N. Why are proteins O-glycosylated?. Trends Biochem. Sci. 15 (1990) 291-294
38. Jepson S., Komatsu M., Haq B., Arango M.E., Huang D., Carraway C.A., and Carraway K.L. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways. Oncogene 21 (2002) 7524-7532
39. Kannagi R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj. J. 14 (1997) 577-584
40. Komatsu M., Carraway C.A., Fregien N.L., and Carraway K.L. Reversible disruption of cell-matrix and cell-cell interactions by overexpression of sialomucin complex. J. Biol. Chem. 272 (1997) 33245-33254
41. Komatsu M., Tatum L., Altman N.H., Carothers Carraway C.A., and Carraway K.L. Potentiation of metastasis by cell surface sialomucin complex (rat MUC4), a multifunctional anti-adhesive glycoprotein. Int. J. Cancer 87 (2000) 480-486
42. Komatsu M., Jepson S., Arango M.E., Carothers Carraway C.A., and Carraway K.L. Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor. Oncogene 20 (2001) 461-470
43. Lasky L.A. Sialomucin ligands for selectins: A new family of cell adhesion molecules. Princess Takamatsu Symp. 24 (1994) 81-90
44. Leroy X., Copin M.C., Devisme L., Buisine M.P., Aubert J.P., Gosselin B., and Porchet N. Expression of human mucin genes in normal kidney and renal cell carcinoma. Histopathology 40 (2002) 450-457
45. Li Y., Bharti A., Chen D., Gong J., and Kufe D. Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol. Cell. Biol. 18 (1998) 7216-7224
46. Li Y., Kuwahara H., Ren J., Wen G., and Kufe D. The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin. J. Biol. Chem. 276 (2001) 6061-6064
47. Li Y., Ren J., Yu W., Li Q., Kuwahara H., Yin L., Carraway III K.L., and Kufe D. The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. J. Biol. Chem. 276 (2001) 35239-35242
48. Li Y., Liu D., Chen D., Kharbanda S., and Kufe D. Human DF3/MUC1 carcinoma-associated protein functions as an oncogene. Oncogene 22 (2003) 6107-6110
49. Ligtenberg M.J., Kruijshaar L., Buijs F., van Meijer M., Litvinov S.V., and Hilkens J. Cell-associated episialin is a complex containing two proteins derived from a common precursor. J. Biol. Chem. 267 (1992) 6171-6177
50. Lilien J., and Balsamo J. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr. Opin. Cell Biol. 17 (2005) 459-465
51. Llinares K., Escande F., Aubert S., Buisine M.P., de Bolos C., Batra S.K., Gosselin B., Aubert J.P., Porchet N., and Copin M.C. Diagnostic value of MUC4 immunostaining in distinguishing epithelial mesothelioma and lung adenocarcinoma. Mod. Pathol. 17 (2004) 150-157
52. Lopez-Ferrer A., Alameda F., Barranco C., Garrido M., and de Bolos C. MUC4 expression is increased in dysplastic cervical disorders. Hum. Pathol. 32 (2001) 1197-1202
53. Marmor M.D., Skaria K.B., and Yarden Y. Signal transduction and oncogenesis by ErbB/HER receptors. Int. J. Radiat. Oncol. Biol. Phys. 58 (2004) 903-913
54. Menard S., Casalini P., Campiglio M., Pupa S., Agresti R., and Tagliabue E. HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer. Ann. Oncol. 12 (2001) S15-S19
55. Moniaux N., Escande F., Batra S.K., Porchet N., Laine A., and Aubert J.P. Alternative splicing generates a family of putative secreted and membrane-associated MUC4 mucins. Eur. J. Biochem. 267 (2000) 4536-4544
56. Moniaux N., Andrianifahanana M., Brand R.E., and Batra S.K. Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy. Br. J. Cancer 91 (2004) 1633-1638
57. Moon R.T., Kohn A.D., De Ferrari G.V., and Kaykas A. WNT and beta-catenin signalling: Diseases and therapies. Nat. Rev. Genet. 5 (2004) 691-701
58. Nagy P., Friedlander E., Tanner M., Kapanen A.I., Carraway K.L., Isola J., and Jovin T.M. Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line. Cancer Res. 65 (2005) 473-482
59. Naidu R., Yadav M., Nair S., and Kutty M.K. Expression of c-erbB3 protein in primary breast carcinomas. Br. J. Cancer 78 (1998) 1385-1390
60. Newburg D.S., Ruiz-Palacios G.M., and Morrow A.L. Human milk glycans protect infants against enteric pathogens. Annu. Rev. Nutr. 25 (2005) 37-58
61. Normanno N., Bianco C., De Luca A., Maiello M.R., and Salomon D.S. Target-based agents against ErbB receptors and their ligands: A novel approach to cancer treatment. Endocr. Relat. Cancer 10 (2003) 1-21
62. Olayioye M.A., Neve R.M., Lane H.A., and Hynes N.E. The ErbB signaling network: Receptor heterodimerization in development and cancer. EMBO J. 19 (2000) 3159-3167
63. Packer L.M., Williams S.J., Callaghan S., Gotley D.C., and McGuckin M.A. Expression of the cell surface mucin gene family in adenocarcinomas. Int. J. Oncol. 25 (2004) 1119-1126
64. Pandey P., Kharbanda S., and Kufe D. Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein. Cancer Res. 55 (1995) 4000-4003
65. Park H.U., Kim J.W., Kim G.E., Bae H.I., Crawley S.C., Yang S.C., Gum Jr. J.R., Batra S.K., Rousseau K., Swallow D.M., Sleisenger M.H., and Kim Y.S. Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia. Pancreas 26 (2003) e48-e54
66. Perez-Vilar J., and Hill R.L. The structure and assembly of secreted mucins. J. Biol. Chem. 274 (1999) 31751-31754
67. Price-Schiavi S.A., Jepson S., Li P., Arango M., Rudland P.S., Yee L., and Carraway K.L. Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance. Int. J. Cancer 99 (2002) 783-791
68. Price-Schiavi S.A., Andrechek E., Idris N., Li P., Rong M., Zhang J., Carothers Carraway C.A., Muller W.J., and Carraway K.L. Expression, location, and interactions of ErbB2 and its intramembrane ligand MUC4 (sialomucin complex) in rat mammary gland during pregnancy. J. Cell Physiol. 203 (2005) 44-53
69. Rakha E.A., Boyce R.W., Abd El-Rehim D., Kurien T., Green A.R., Paish E.C., Robertson J.F., and Ellis I.O. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod. Pathol. 18 (2005) 1295-1304
70. Ramsauer V.P., Carraway C.A., Salas P.J., and Carraway K.L. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, translocates ErbB2 to the apical surface in polarized epithelial cells. J. Biol. Chem. 278 (2003) 30142-30147
71. Ramsauer V.P., Pino V., Farooq A., Carothers Carraway C.A., Salas P.J., and Carraway K.L. Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2. Mol. Biol. Cell 19 (2006) (in press)
72. Ratan H.L., Gescher A., Steward W.P., and Mellon J.K. ErbB receptors: Possible therapeutic targets in prostate cancer?. BJU Int. 92 (2003) 890-895
73. Ren J., Li Y., and Kufe D. Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling. J. Biol. Chem. 277 (2002) 17616-17622
74. Ren J., Agata N., Chen D., Li Y., Yu W.H., Huang L., Raina D., Chen W., Kharbanda S., and Kufe D. Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Cancer Cell 5 (2004) 163-175
75. Ren J., Bharti A., Raina D., Chen W., Ahmad R., and Kufe D. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90. Oncogene 25 (2006) 20-31
76. Riese II D.J., and Stern D.F. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 20 (1998) 41-48
77. Ross J.S., and McKenna B.J. The HER-2/neu oncogene in tumors of the gastrointestinal tract. Cancer Invest. 19 (2001) 554-568
78. Rossi E.A., McNeer R.R., Price-Schiavi S.A., Van den Brande J.M., Komatsu M., Thompson J.F., Carraway C.A., Fregien N.L., and Carraway K.L. Sialomucin complex, a heterodimeric glycoprotein complex. Expression as a soluble, secretable form in lactating mammary gland and colon. J. Biol. Chem. 271 (1996) 33476-33485
79. Ruvoen-Clouet N., Mas E., Marionneau S., Guillon P., Lombardo D., and Le Pendu J. Bile-salt-stimulated lipase and mucins from milk of 'secretor' mothers inhibit the binding of Norwalk virus capsids to their carbohydrate ligands. Biochem. J. 393 (2006) 627-634
80. Schaefer K.L., Brachwitz K., Wai D.H., Braun Y., Diallo R., Korsching E., Eisenacher M., Voss R., Van Valen F., Baer C., Selle B., Spahn L., et al. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3. Cancer Res. 64 (2004) 3395-3405
81. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 103 (2000) 211-225
82. Schroeder J.A., Thompson M.C., Gardner M.M., and Gendler S.J. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J. Biol. Chem. 276 (2001) 13057-13064
83. Schroeder J.A., Adriance M.C., Thompson M.C., Camenisch T.D., and Gendler S.J. MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion. Oncogene 22 (2003) 1324-1332
84. Schroeder J.A., Masri A.A., Adriance M.C., Tessier J.C., Kotlarczyk K.L., Thompson M.C., and Gendler S.J. MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation. Oncogene 23 (2004) 5739-5747
85. Sgambato A., Cittadini A., Faraglia B., and Weinstein I.B. Multiple functions of p27(Kip1) and its alterations in tumor cells: A review. J. Cell. Physiol. 183 (2000) 18-27
86. Shelton J.G., Steelman L.S., Abrams S.L., Bertrand F.E., Franklin R.A., McMahon M., and McCubrey J.A. The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: What's genetics got to do with it?. Expert Opin. Ther. Target. 9 (2005) 1009-1030
87. Sheng Z.Q., Hull S.R., and Carraway K.L. Biosynthesis of the cell surface sialomucin complex of ascites 13762 rat mammary adenocarcinoma cells from a high molecular weight precursor. J. Biol. Chem. 265 (1990) 8505-8510
88. Shibahara H., Tamada S., Higashi M., Goto M., Batra S.K., Hollingsworth M.A., Imai K., and Yonezawa S. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology 39 (2004) 220-229
89. Shintani S., Funayama T., Yoshihama Y., Alcalde R.E., and Matsumura T. Prognostic significance of ERBB3 overexpression in oral squamous cell carcinoma. Cancer Lett. 95 (1995) 79-83
90. Singh A.P., Moniaux N., Chauhan S.C., Meza J.L., and Batra S.K. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Res. 64 (2004) 622-630
91. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., and McGuire W.L. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235 (1987) 177-182
92. Smalley M.J., and Dale T.C. Wnt signaling and mammary tumorigenesis. J. Mammary Gland Biol. Neoplasia 6 (2001) 37-52
93. Spicer A.P., Rowse G.J., Lidner T.K., and Gendler S.J. Delayed mammary tumor progression in Muc-1 null mice. J. Biol. Chem. 270 (1995) 30093-30101
94. Strous G.J., and Dekker J. Mucin-type glycoproteins. Crit. Rev. Biochem. Mol. Biol. 27 (1992) 57-92
95. Swan J.S., Arango M.E., Carothers Carraway C.A., and Carraway K.L. An ErbB2-Muc4 complex in rat ocular surface epithelia. Curr. Eye Res. 24 (2002) 397-402
96. Swartz M.J., Batra S.K., Varshney G.C., Hollingsworth M.A., Yeo C.J., Cameron J.L., Wilentz R.E., Hruban R.H., and Argani P. MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am. J. Clin. Pathol. 117 (2002) 791-796
97. Taylor-Papadimitriou J., Burchell J., Miles D.W., and Dalziel M. MUC1 and cancer. Biochim. Biophys. Acta 1455 (1999) 301-313
98. Thornton D.J., and Sheehan J.K. From mucins to mucus: Toward a more coherent understanding of this essential barrier. Proc. Am. Thorac. Soc. 1 (2004) 54-61
99. Wakeling A.E. Inhibitors of growth factor signalling. Endocr. Relat. Cancer 12 (2005) S183-S187
100. Wang S.C., and Hung M.C. HER2 overexpression and cancer targeting. Semin. Oncol. 28 (2001) 115-124
101. Wang R., Khatri I.A., and Forstner J.F. C-terminal domain of rodent intestinal mucin Muc3 is proteolytically cleaved in the endoplasmic reticulum to generate extracellular and membrane components. Biochem. J. 366 (2002) 623-631
102. Wang H., Lillehoj E.P., and Kim K.C. Identification of four sites of stimulated tyrosine phosphorylation in the MUC1 cytoplasmic tail. Biochem. Biophys. Res. Commun. 310 (2003) 341-346
103. Wei X., Xu H., and Kufe D. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell 7 (2005) 167-178
104. Wei X., Xu H., and Kufe D. MUC1 oncoprotein stabilizes and activates estrogen receptor alpha. Mol. Cell 21 (2006) 295-305
105. Wen Y., Caffrey T.C., Wheelock M.J., Johnson K.R., and Hollingsworth M.A. Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin. J. Biol. Chem. 278 (2003) 38029-38039
106. Wesseling J., van der Valk S.W., Hilkens J., Hilkens J., Wesseling J., Vos H.L., Storm J., Boer B., van der Valk S.W., and Maas M.C. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol. Biol. Cell 7 (1996) 565-577
107. Williams S.J., Munster D.J., Quin R.J., Gotley D.C., and McGuckin M.A. The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. Biochem. Biophys. Res. Commun. 261 (1999) 83-89
108. Yarden Y., and Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2 (2001) 127-137
109. Yamamoto M., Bharti A., Li Y., and Kufe D. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion. J. Biol. Chem. 272 (1997) 12492-12494
110. Zhang J., Perez A., Yasin M., Soto P., Rong M., Theodoropoulos G., Carothers Carraway C.A., and Carraway K.L. Presence of MUC4 in human milk and at the luminal surfaces of blood vessels. J. Cell. Physiol. 204 (2005) 166-177
111. Zrihan-Licht S., Vos H.L., Baruch A., Elroy-Stein O., Sagiv D., Keydar I., Hilkens J., and Wreschner D.H. Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue. Eur. J. Biochem. 224 (1994) 787-795
112. Zrihan-Licht S., Baruch A., Elroy-Stein O., Keydar I., and Wreschner D.H. Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules. FEBS Lett. 356 (1994) 130-136